10.6084/m9.figshare.5671603.v1
Thiago Gonçalves dos Santos Martins
Thiago Gonçalves dos Santos
Martins
Ana Luiza Fontes de Azevedo Costa
Ana Luiza Fontes de Azevedo
Costa
Karina Mie Furuzawa
Karina
Mie Furuzawa
Milton Ruiz Alves
Milton Ruiz
Alves
Roger Chammas
Roger
Chammas
Evaluation of preoperative subconjunctival single application of mitomycin C in primary pterygium
SciELO journals
2017
Mitomycin/therapeutic use
Pterygium/surgery
Pterygium/drug therapy
Recurrence
2017-12-05 16:09:33
Dataset
https://scielo.figshare.com/articles/dataset/Evaluation_of_preoperative_subconjunctival_single_application_of_mitomycin_C_in_primary_pterygium/5671603
<p></p><p>Abstract Pterygia are usually benign lesions that do not require specific treatment. It is a fibrovascular growth onto the nasal side of the cornea. It`s cause has not been fully elucidated yet, but seems to be related to long -term ultraviolet ray exposure. When symptoms are not controlled with conservative treatment surgery is considered, but the recurrence rate is still high, and efforts have been made to avoid it. Mitomycin C (MMC) is a fibroblast proliferation inhibitor that can be used as adjuvant to surgery to reduce recurrence. We report here a case that describes pterygium surgery performed in both eyes of the same patient, being one with MMC and the other eye without it. Both pterygium were sent to laboratory analysis. The results and proliferation index were compared between the eyes.</p><p></p>